Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
about
Immune therapy in inflammatory bowel disease and models of colitis.Functional genomics in gastroenterologyPharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes.Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases.Vitamin D-mediated calcium absorption in patients with clinically stable Crohn's disease: a pilot study.Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaquesBriakinumab for treatment of Crohn's disease: results of a randomized trialReview article: exploration of the genetic aetiology of inflammatory bowel disease--implications for diagnosis and therapy.Toxicity of infliximab in the course of treatment of Crohn's disease.Infliximab for the treatment of pouchitisRole of cytokines in inflammatory bowel disease.Psoriasiform eruption induced by infliximab.Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition.Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease.
P2860
Q30774968-9CB3FB2B-DE72-4632-9639-73C4869C1E77Q30942866-88837B0C-AD1F-4D54-94EB-62E59C4B4F89Q30977623-399BDAE8-8928-4ADB-8BAF-27B4A83E59AAQ33904308-128992EE-8EC7-4023-871B-32214EAC3294Q34019290-717F412C-BBAD-4936-A3EF-02C23B0B36FDQ34177131-F62AA51E-94D7-45EF-8651-55E16AB59235Q35106331-A7DE8C84-8376-43CE-999D-07DB13F1C4AEQ35670615-9A64FB8F-DB55-426E-9CAB-643E8B59E71BQ35880358-F51028EC-7191-4EBD-AC9C-85F6BAE4BB20Q36349717-AE45D2F1-8FB1-4055-966C-584ECBBA3485Q38168531-FC6BDA37-39E9-4EC9-B715-0483E9358723Q43065113-80DBB26E-BAEE-4626-B90E-70D98C537140Q44741635-4B5DFBA7-3598-4931-8179-F8829A60B29EQ50920142-EAD44346-2ABF-4536-98C0-9068BF705EB4Q53433625-67CAD934-F8DD-46D4-9C52-B771FEA4DCD8
P2860
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
@ast
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
@en
type
label
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
@ast
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
@en
prefLabel
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
@ast
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
@en
P921
P356
P1476
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.
@en
P2093
Rutgeerts PR
P2888
P356
10.1007/S003840050182
P577
1999-02-01T00:00:00Z
P6179
1009782211